FIP Abu Dhabi 2019

D19 - What’s new in industry and science? Part 2

Conference Hall A - Section D

Chairs

Takuya Kumamoto (Hiroshima University, Japan) and Masaru Kato (Showa University, Japan)

Introduction

Short oral presentations selected from submitted abstracts

Programme

09:00 – 09:10 Introduction by the chair

  1. 09:10 – 09:20 Comparative study of physiochemical properties of Furosemide injection in Enugu State, Nigeria
    Ngozi Udem (University of Nigeria Teaching Hospital, Nigeria)
  2. 09:20 – 09:30 Rapid quantitative analytical methods of liposomal drugs and Exosome
    Masaru Kato (Showa University, Japan)
  3. 09:30 – 09:40 Cationic gelatin nanoparticles for gene delivery: Characterization and monolayer study
    Osama Madkhali (Jazan University, Kingdom of Saudi Arabia)
  4. 09:40 – 09:50 Design of kappa opioid receptor modulators using Salvinorin a as a lead for addiction management
    Claire Shoemake (University of Malta, Malta)
  5. 09:50 – 10:00 Skin disposition of Rhododendrol in aqueous and complex vehicles under ’in-use’ conditions
    Florencio jr. Villester Arce (Josai University, Japan)
  6. 10:00 – 10:10 Characterisation and release profile of GNE emulsion against osteomyelitic gram-positive bacteria
    Mohd Affendi Bin Mohd Shafri  (Kulliyah of Allied Health Sciences, Malaysia)

10:10 – 10:20 Q & A

10:20 – 10:40 Coffee/tea break

  1. 10:40 – 10:50 Folate anchored solid lipid nanoparticle of Paclitaxel for lung squamous carcinoma cell targeting
    Vaibhav Rajoriya (Dr Hari Singh Gour University, India)
  2. 10:50 – 11:00 Impact of key starting material on regulatory compliance: An evaluation of ferric ammonium citrate
    Forum Janak Jalundhwala (Shreenath Chemicals, India)
  3. 11:00 – 11:10 Earlier access to innovation: Adaptive licensing combined with risk sharing – interim results
    Bärbel Holbein (University of Bremen, Germany)

11:10 – 11:25 Q & A and conclusion by the chair

11:25 – 11:30 Room refresh                                                                    

Learning Objectives

At the end of this section, participants will be able to:

  1. List innovations and new discoveries in industry and pharmaceutical science
  2. State new initiatives in industry and pharmaceutical science that can be adapted based on presented information;
  3. Share actionable application of results of recent studies in industry and pharmaceutical science.

 

Type of session: Knowledge based